- Filed
- Jan 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Jan 14, 2026 | 5.8M sh |
| Shares Diluted | Q1 2026 · Nov 30, 2025 | 5.8M sh |
| Shares Diluted | Q1 2026 · Nov 30, 2024 | 4.72M sh |
| Operating Cash Flow | Q1 2026 · Nov 30, 2025 | −$10.1K |
| Operating Cash Flow | Q1 2026 · Nov 30, 2024 | −$19.06K |
| Cash And Equivalents | Q1 2026 · Nov 30, 2025 | $4K |
| Cash And Equivalents | Q1 2026 · Aug 31, 2025 | $6.83K |
| Stockholders Equity | Q1 2026 · Nov 30, 2025 | −$79.29K |
| Stockholders Equity | Q1 2026 · Aug 31, 2025 | −$59.71K |
| Stockholders Equity | Q1 2026 · Nov 30, 2024 | −$20.02K |
| Stockholders Equity | Q1 2026 · Aug 31, 2024 | −$30.81K |
| Current Liabilities | Q1 2026 · Nov 30, 2025 | $220.15K |
| Current Liabilities | Q1 2026 · Aug 31, 2025 | $200.99K |
| Total Liabilities | Q1 2026 · Nov 30, 2025 | $220.15K |
| Total Liabilities | Q1 2026 · Aug 31, 2025 | $200.99K |
| Current Assets | Q1 2026 · Nov 30, 2025 | $35.37K |
| Current Assets | Q1 2026 · Aug 31, 2025 | $27.1K |
| Total Assets | Q1 2026 · Nov 30, 2025 | $140.87K |
| Total Assets | Q1 2026 · Aug 31, 2025 | $141.28K |
| Eps Diluted | Q1 2026 · Nov 30, 2025 | $0.00 |
| Eps Diluted restated | Q1 2026 · Nov 30, 2024 | $0.00 |
| Sga Expense | Q1 2026 · Nov 30, 2025 | $29.19K |
| Sga Expense | Q1 2026 · Nov 30, 2024 | $16.58K |
| Net Income | Q1 2026 · Nov 30, 2025 | −$22.01K |
| Net Income | Q1 2026 · Nov 30, 2024 | −$14.51K |
| Operating Income | Q1 2026 · Nov 30, 2025 | −$19.58K |
| Operating Income | Q1 2026 · Nov 30, 2024 | −$12.16K |
| Gross Profit | Q1 2026 · Nov 30, 2025 | $9.61K |
| Gross Profit | Q1 2026 · Nov 30, 2024 | $4.42K |
| Cost Of Revenue | Q1 2026 · Nov 30, 2025 | $9.61K |
| Revenue | Q1 2026 · Nov 30, 2025 | $9.61K |
| Revenue | Q1 2026 · Nov 30, 2024 | $4.45K |